Display Settings:

Format
Sort by

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

    Results: 4

    1.

    Setting occupational exposure limits for unstudied pharmaceutical intermediates using an in vitro parallelogram approach.

    Maier MS.

    Toxicol Mech Methods. 2011 Feb;21(2):76-85. doi: 10.3109/15376511003638280. Epub 2010 Feb 15.

    PMID:
    20156007
    [PubMed - indexed for MEDLINE]
    2.

    Differentiating primary human cells in rapid-throughput discovery applications.

    Marshak DR, Greenwalt DE.

    Methods Mol Biol. 2007;356:121-8.

    PMID:
    16988399
    [PubMed - indexed for MEDLINE]
    3.

    Kinetic characterization and in vitro toxicity evaluation of a luciferase less susceptible to HPV chemical inhibition.

    Kim-Choi E, Danilo C, Kelly J, Carroll R, Shonnard D, Rybina I.

    Toxicol In Vitro. 2006 Dec;20(8):1537-47. Epub 2006 Jul 12.

    PMID:
    16962283
    [PubMed - indexed for MEDLINE]
    4.

    Creating a mutant luciferase resistant to HPV chemical inhibition by random mutagenesis and colony-level screening.

    Kim-Choi E, Danilo C, Kelly J, Carroll R, Shonnard D, Rybina I.

    Luminescence. 2006 May-Jun;21(3):135-42.

    PMID:
    16502391
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Search details

      See more...

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk